Brenus Pharma
Developer of anti-cancer cell-based immunotherapy designed to generate allogeneic cell vaccines for solid tumors. The company platform empowers immune cells in vivo to fight cancer through two core me...
Valuation
$45.4M
Market implied
Share Price
N/A
Total Raised
$30M
Last Round
N/A